Jushi Holdings (JUSHF) Change in Receivables (2021 - 2026)
Jushi Holdings' (JUSHF) quarterly Change in Receivables came in at -$396000.0 in Q1 2026, down 121.41% year-on-year from $1.8 million in Q1 2025, and down 144.95% on a QoQ basis from $881000.0 in Q4 2025.
Jushi Holdings (JUSHF) Change in Receivables (2021 - 2026) Analysis & Trends
Jushi Holdings (JUSHF) has 6 years of Change in Receivables data on file, last reported at -$396000.0 in Q1 2026.
- On a quarterly basis, Change in Receivables fell 121.41% year-over-year to -$396000.0 in Q1 2026; TTM through Mar 2026 was -$1.1 million, a 382.12% decrease from a year earlier, with the FY2025 full-year figure at $1.1 million, up 160.44% from the prior year.
- Change in Receivables for Q1 2026 stood at -$396000.0, down from $881000.0 in the prior quarter.
- Over the last five years, Change in Receivables for JUSHF reached as high as $1.8 million in Q1 2025 and fell as low as -$2.8 million in Q2 2025.
- Historically, Change in Receivables has averaged $166294.1 across 5 years, with a median of $511000.0 in 2022.
- On a YoY basis, Change in Receivables climbed as much as 551.22% in 2025 and fell as far as 184.03% in 2025.
- Year by year, Change in Receivables stood at $1.5 million in 2022, then tumbled by 43.93% to $855000.0 in 2023, then slumped by 123.51% to -$201000.0 in 2024, then soared by 538.31% to $881000.0 in 2025, then sank by 144.95% to -$396000.0 in 2026.
- Per Business Quant data, the three most recent Change in Receivables figures were -$396000.0 in Q1 2026, $881000.0 in Q4 2025, and $1.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -78.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 106.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -621.82 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -38.20 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 126.30 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 81.40 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Jushi Holdings | 81.25 Mn | 41.54 Mn | 29.88 Mn | -396,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -396,000.00 |
| Mar 31, 2026 | -396,000.00 |
| Dec 31, 2025 | 881,000.00 |
| Dec 31, 2025 | 881,000.00 |
| Sep 30, 2025 | 1.19 Mn |
| Sep 30, 2025 | 1.19 Mn |
| Jun 30, 2025 | -2.79 Mn |
| Jun 30, 2025 | -2.79 Mn |
| Mar 31, 2025 | 1.85 Mn |
| Mar 31, 2025 | 1.85 Mn |
| Dec 31, 2024 | -201,000.00 |
| Dec 31, 2024 | -201,000.00 |
| Sep 30, 2024 | -269,000.00 |
| Sep 30, 2024 | -269,000.00 |
| Jun 30, 2024 | -983,000.00 |
| Jun 30, 2024 | -983,000.00 |
| Mar 31, 2024 | -410,000.00 |
| Mar 31, 2024 | -410,000.00 |
| Dec 31, 2023 | 855,000.00 |
| Dec 31, 2023 | 855,000.00 |